Boston Medical Center Corporation, Boston, MA – FDA Inspections

Inspection records and compliance data for Boston Medical Center Corporation in Boston, Massachusetts. 8 FDA inspections on record, last inspected May 02, 2025.

Company Profile

This profile covers Boston Medical Center Corporation based in Boston, Massachusetts, United States.

FDA Inspection History

FDA inspections: 8
OAI: 0
VAI: 3
NAI: 4
Unclassified: 1
Form 483s: 0
Warning letters: 0

First inspected January 14, 2010. Last inspected May 2, 2025.

Most cited issue areas

Biological product deviation report1 inspection
Establish, maintain and follow manufacturing SOPs1 inspection
Maintain and clean equipment1 inspection

FDA inspections (8)

Date	Result	FDA center(s)	Insp. #
May 2, 2025	Not classified	Biologics	1270738
September 12, 2023	NAI	Biologics · Blood and Blood Products	1218229
May 16, 2019	NAI	Biologics · Blood and Blood Products	1091871
March 18, 2016	VAI	Biologics · Blood and Blood Products	963517
February 3, 2014	NAI	Biologics · Blood and Blood Products	864614
December 27, 2011	VAI	Biologics · Blood and Blood Products	759061
May 19, 2010	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	663693
January 14, 2010	VAI	Biologics · Blood and Blood Products	638735

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Ellis Neufeld, M.D., Ph.D.

American Red Cross Blood Services

North Shore Medical Center/Union Hospital Campus

MetaGen Corp.

Allotex, Inc

Robert H. Brown Jr., M.D.

Lawrence General Hospital Department of Laboratory Medicine

Hemanext Inc

Lowell General Hospital-Saints Campus

Vanguard Health Systems Acquisition Subsidiary#7, Inc. dba